Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 264

1.

GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis.

Vieira-Sousa E, Alves P, Rodrigues AM, Teixeira F, Tavares-Costa J, Bernardo A, Pimenta S, Pimentel-Santos FM, Gomes JL, Aguiar R, Pinto P, Videira T, Catita C, Santos H, Borges J, Sequeira G, Ribeiro C, Teixeira L, Ávila-Ribeiro P, Martins FM, Canhão H, McInnes IB, Ribeiro RM, Fonseca JE.

Ann Rheum Dis. 2020 Apr;79(4):490-498. doi: 10.1136/annrheumdis-2019-216500.

2.

NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium.

Manuel Sánchez-Maldonado J, Martínez-Bueno M, Canhão H, Ter Horst R, Muñoz-Peña S, Moñiz-Díez A, Rodríguez-Ramos A, Escudero A, Sorensen SB, Hetland ML, Ferrer MA, Glintborg B, Filipescu I, Pérez-Pampin E, Conesa-Zamora P, García A, den Broeder A, De Vita S, Hove Jacobsen SE, Collantes E, Quartuccio L, Netea MG, Li Y, Fonseca JE, Jurado M, López-Nevot MÁ, Coenen MJH, Andersen V, Cáliz R, Sainz J.

Sci Rep. 2020 Mar 9;10(1):4316. doi: 10.1038/s41598-020-61331-5.

3.

Transition in a Paediatric Rheumatology Unit - experience from a tertiary unit.

Martins P, Barreira SC, Melo AT, Campanilho-Marques R, Costa-Reis P, Fonseca JE, Oliveira-Ramos F.

Acta Reumatol Port. 2019 Nov 15. [Epub ahead of print]

PMID:
32008033
4.

Cell sources of inflammatory mediators present in bone marrow areas inside the meniscus.

Rocha FAC, Girão VCC, Nunes RM, Pinto ACMD, Vidal B, Fonseca JE.

PLoS One. 2019 Dec 20;14(12):e0226986. doi: 10.1371/journal.pone.0226986. eCollection 2019.

5.

Increased monohexosylceramide levels in the serum of established rheumatoid arthritis patients.

Miltenberger-Miltenyi G, Cruz-Machado AR, Saville J, Conceição VA, Calado Â, Lopes I, Fuller M, Fonseca JE.

Rheumatology (Oxford). 2019 Dec 6. pii: kez545. doi: 10.1093/rheumatology/kez545. [Epub ahead of print]

PMID:
31808525
6.

Efficacy, immunogenicity and cost analysis of a systematic switch from originator infliximab to biosimilar CT-P13 of all patients with inflammatory arthritis from a single center.

Valido A, Silva-Dinis J, Saavedra MJ, Iria I, Gonçalves J, Lopes JP, Fonseca JE.

Acta Reumatol Port. 2019 Nov 22. [Epub ahead of print]

PMID:
31754088
7.

How to investigate: Pre-clinical rheumatoid arthritis.

Martins P, Fonseca JE.

Best Pract Res Clin Rheumatol. 2019 Aug;33(4):101438. doi: 10.1016/j.berh.2019.101438. Epub 2019 Oct 15. Review.

PMID:
31627994
8.

Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium.

Sánchez-Maldonado JM, Cáliz R, Canet L, Horst RT, Bakker O, den Broeder AA, Martínez-Bueno M, Canhão H, Rodríguez-Ramos A, Lupiañez CB, Soto-Pino MJ, García A, Pérez-Pampin E, González-Utrilla A, Escudero A, Segura-Catena J, Netea-Maier RT, Ferrer MÁ, Collantes-Estevez E, López Nevot MÁ, Li Y, Jurado M, Fonseca JE, Netea MG, Coenen MJH, Sainz J.

Sci Rep. 2019 Oct 15;9(1):14812. doi: 10.1038/s41598-019-51255-0.

9.

Biosimilars in rheumatology.

Araújo FC, Gonçalves J, Fonseca JE.

Pharmacol Res. 2019 Nov;149:104467. doi: 10.1016/j.phrs.2019.104467. Epub 2019 Sep 27. Review.

PMID:
31568820
10.

Rheuma SPACE - Standard Practice Aiming Clinical Excellence: description of the methodological approach.

Macieira C, Cunha-Miranda L, Nero P, Laires P, Bogas M, Farinha S, Freitas I, Lucas P, Sousa J, Narciso L, Mateus E, Canas da Silva J, Fonseca JE, Study Group RS.

Acta Reumatol Port. 2019 Sep 8. [Epub ahead of print]

11.

Dexamethasone for the treatment of class I HELLP syndrome: A double-blind, placebo-controlled, multicenter, randomized clinical trial.

Fonseca JE, Otero JC, Messa C.

Pregnancy Hypertens. 2019 Jul;17:158-164. doi: 10.1016/j.preghy.2019.06.003. Epub 2019 Jun 17. No abstract available.

PMID:
31487635
12.

Efficacy, safety and sample quality of ultrasound-guided synovial needle biopsy in clinical practice and research: a prospective observational study.

Romão VC, Polido-Pereira J, Barros R, Luís R, Vidal B, Vieira-Sousa E, Vitorino E, Humby F, Kelly S, Pitzalis C, Saraiva F, Fonseca JE.

Arthritis Care Res (Hoboken). 2019 Aug 17. doi: 10.1002/acr.24050. [Epub ahead of print]

PMID:
31421034
13.

Low Serum Levels of DKK2 Predict Incident Low-Impact Fracture in Older Women.

Rodrigues AM, Eusébio M, Rodrigues AB, Caetano-Lopes J, Lopes IP, Lopes A, Mendes JM, Coelho PS, Fonseca JE, Branco JC, Canhão H.

JBMR Plus. 2019 Mar 28;3(7):e10179. doi: 10.1002/jbm4.10179. eCollection 2019 Jul.

14.

Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese Register.

Vieira-Sousa E, Eusébio M, Ávila-Ribeiro P, Khmelinskii N, Cruz-Machado R, Martins Rocha T, Bernardes M, Santos-Faria D, Leite Silva J, Santos H, Miguel C, Carvalho P, Costa T, Duarte AC, Meirinhos T, Nero P, Fonseca JE, Santos MJ.

J Rheumatol. 2019 Aug 1. pii: jrheum.181272. doi: 10.3899/jrheum.181272. [Epub ahead of print]

PMID:
31371659
15.

Outcomes of rheumatic patients referred from Portuguese speaking African countries for medical evaluation in Portugal.

Teixeira V, Barreira S, Valido A, Macieira C, Fonseca JE.

Acta Reumatol Port. 2019 Jul 22. [Epub ahead of print]

16.

Major Challenges in Rheumatology: Will We Ever Treat Smarter, Instead of Just Harder?

Romão VC, Fonseca JE.

Front Med (Lausanne). 2019 Jun 26;6:144. doi: 10.3389/fmed.2019.00144. eCollection 2019. No abstract available.

17.

Predictors and causes of first-line biologic agent discontinuation in rheumatoid arthritis: data from Reuma.pt.

Gomes JL, Sepriano A, Eusébio M, Serra S, Fonseca JE, Saavedra MJ, Cunha-Miranda L, Silva C, Bernardes M, Rosa-Gonçalves D, Costa J, Castelão W, Branco JC, Santos MJ.

Acta Reumatol Port. 2019 Jan-Mar;44(1):57-64.

18.

Anti-TNF Drugs for Chronic Uveitis in Adults-A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Leal I, Rodrigues FB, Sousa DC, Duarte GS, Romão VC, Marques-Neves C, Costa J, Fonseca JE.

Front Med (Lausanne). 2019 May 24;6:104. doi: 10.3389/fmed.2019.00104. eCollection 2019.

19.

Validation of a predictive model for successful vaginal birth after cesarean section.

Fonseca JE, Rodriguez JL, Maya Salazar D.

Colomb Med (Cali). 2019 Mar 30;50(1):13-21. doi: 10.25100/cm.v50i1.2521.

20.

Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial.

Sanmarti R, Veale DJ, Martin-Mola E, Escudero-Contreras A, González C, Ercole L, Alonso R, Fonseca JE; ToSpace Study Group.

Arthritis Rheumatol. 2019 Oct;71(10):1616-1625. doi: 10.1002/art.40905. Epub 2019 Sep 24.

PMID:
31087542
21.

Undifferentiated connective tissue disease: state of the art on clinical practice guidelines.

Antunes M, Scirè CA, Talarico R, Alexander T, Avcin T, Belocchi C, Doria A, Franceschini F, Galetti I, Govoni M, Hachulla E, Launay D, Lepri G, Macieira C, Matucci-Cerinic M, Montecucco CM, Moraes-Fontes MF, Mouthon L, Paolino S, Ramoni V, Tani C, Tas SW, Tincani A, Van Vollenhoven R, Zen M, Fonseca J, Bombardieri S, Fonseca JE, Schneider M, Smith V, Cutolo M, Mosca M, Beretta L.

RMD Open. 2019 Feb 26;4(Suppl 1):e000786. doi: 10.1136/rmdopen-2018-000786. eCollection 2018. Review.

22.

Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected].

Meyer A, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Barsotti S, Beretta L, Blagojevic J, Burmester G, Cavazzana I, Cherrin P, Damian L, Doria A, Fonseca JE, Furini F, Galetti I, Houssiau F, Krieg T, Maddalena L, Launay D, Campanilho-Marques R, Martin T, Matucci-Cerinic M, Moinzadeh P, Montecucco C, Moraes-Fontes MF, Mouthon L, Neri R, Paolino S, Piette Y, Rednic S, Tamirou F, Tincani A, Toplak N, Bombardieri S, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Cavagna L.

RMD Open. 2019 Feb 26;4(Suppl 1):e000784. doi: 10.1136/rmdopen-2018-000784. eCollection 2018. Review. Erratum in: RMD Open. 2019 Apr 15;5(1):e000784corr1.

23.

Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.

Canet LM, Sánchez-Maldonado JM, Cáliz R, Rodríguez-Ramos A, Lupiañez CB, Canhão H, Martínez-Bueno M, Escudero A, Segura-Catena J, Sorensen SB, Hetland ML, Soto-Pino MJ, Ferrer MA, García A, Glintborg B, Filipescu I, Pérez-Pampin E, González-Utrilla A, Nevot MÁL, Conesa-Zamora P, den Broeder A, De Vita S, Jacobsen SEH, Collantes-Estevez E, Quartuccio L, Canzian F, Fonseca JE, Coenen MJH, Andersen V, Sainz J.

Pharmacogenomics J. 2019 Dec;19(6):582. doi: 10.1038/s41397-019-0084-2.

PMID:
30760878
24.

Ultrasound and its clinical use in rheumatoid arthritis: where do we stand?

do Prado AD, Staub HL, Bisi MC, da Silveira IG, Mendonça JA, Polido-Pereira J, Fonseca JE.

Adv Rheumatol. 2018 Aug 2;58(1):19. doi: 10.1186/s42358-018-0023-y. Review.

PMID:
30657086
25.

Telerheumatology - breaking barriers to access care in Rheumatology.

Teixeira V, Cordeiro I, Gonçalves MJ, Fonseca JE, Macieira C.

Acta Reumatol Port. 2018 Oct-Dec;43(4):253-255.

26.

Diet, Microbiota, and Gut Permeability-The Unknown Triad in Rheumatoid Arthritis.

Guerreiro CS, Calado Â, Sousa J, Fonseca JE.

Front Med (Lausanne). 2018 Dec 14;5:349. doi: 10.3389/fmed.2018.00349. eCollection 2018. Review.

27.

Correction to: Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups.

Najm A, Le Goff B, Orr C, Thurlings R, Cañete JD, Humby F, Alivernini S, Manzo A, Just SA, Romão VC, Krenn V, Müller-Ladner U, Addimanda O, Tas SW, Stoenoiu M, de Bellefon LM, Durez P, Strand V, Wechalekar MD, Fonseca JE, Lauwerys B, Fearon U, Veale DJ; EULAR Synovitis Study Group and OMERACT Synovial Tissue Special Interest Group.

Arthritis Res Ther. 2018 Dec 19;20(1):282. doi: 10.1186/s13075-018-1795-5.

28.

Effects of tofacitinib in early arthritis-induced bone loss in an adjuvant-induced arthritis rat model.

Vidal B, Cascão R, Finnilä MAJ, Lopes IP, da Glória VG, Saarakkala S, Zioupos P, Canhão H, Fonseca JE.

Rheumatology (Oxford). 2019 Feb 1;58(2):371. doi: 10.1093/rheumatology/key377. No abstract available.

PMID:
30544153
29.

The Added Value of a Vasculitis Clinic in a Tertiary Referral Hospital.

Khmelinskii N, Seixas MI, Ponte C, Fonseca JE, Macieira C.

Acta Med Port. 2018 Nov 30;31(11):614-617. doi: 10.20344/amp.9875. Epub 2018 Nov 30. No abstract available.

30.

Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups.

Najm A, Le Goff B, Orr C, Thurlings R, Cañete JD, Humby F, Alivernini S, Manzo A, Just SA, Romão VC, Krenn V, Müller-Ladner U, Addimanda O, Tas SW, Stoenoiu M, Meric de Bellefon L, Durez P, Strand V, Wechalekar MD, Fonseca JE, Lauwerys B, Fearon U, Veale DJ; EULAR Synovitis Study Group and OMERACT Synovial Tissue Special Interest Group.

Arthritis Res Ther. 2018 Dec 3;20(1):265. doi: 10.1186/s13075-018-1762-1. Erratum in: Arthritis Res Ther. 2018 Dec 19;20(1):282.

31.

Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across Europe.

Just SA, Humby F, Lindegaard H, Meric de Bellefon L, Durez P, Vieira-Sousa E, Teixeira R, Stoenoiu M, Werlinrud J, Rosmark S, Larsen PV, Pratt A, Choy E, Gendi N, Buch MH, Edwards CJ, Taylor PC, McInnes IB, Fonseca JE, Pitzalis C, Filer A.

RMD Open. 2018 Oct 26;4(2):e000799. doi: 10.1136/rmdopen-2018-000799. eCollection 2018.

32.

Antiphospholipid syndrome: state of the art on clinical practice guidelines.

Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM, Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM, Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A.

RMD Open. 2018 Oct 18;4(Suppl 1):e000785. doi: 10.1136/rmdopen-2018-000785. eCollection 2018.

33.

Mixed connective tissue disease: state of the art on clinical practice guidelines.

Chaigne B, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Beretta L, Doria A, Guffroy A, Guimarães V, Hachulla É, Krieg T, Launay D, Lepri G, Moinzadeh P, Müller-Ladner U, Rednic S, Rodrigues A, Tas SW, van Vollenhoven RF, Vieira A, Bombardieri S, Fonseca JE, Galetti I, Schneider M, Smith V, Cutolo M, Mosca M, Fischer-Betz R.

RMD Open. 2018 Oct 18;4(Suppl 1):e000783. doi: 10.1136/rmdopen-2018-000783. eCollection 2018.

34.

How to treat patients with rheumatoid arthritis when methotrexate has failed? The use of a multiple propensity score to adjust for confounding by indication in observational studies.

Bergstra SA, Winchow LL, Murphy E, Chopra A, Salomon-Escoto K, Fonseca JE, Allaart CF, Landewé RBM.

Ann Rheum Dis. 2019 Jan;78(1):25-30. doi: 10.1136/annrheumdis-2018-213731. Epub 2018 Oct 16.

PMID:
30327328
35.

Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.

Canet LM, Sánchez-Maldonado JM, Cáliz R, Rodríguez-Ramos A, Lupiañez CB, Canhão H, Martínez-Bueno M, Escudero A, Segura-Catena J, Sorensen SB, Hetland ML, Soto-Pino MJ, Ferrer MA, García A, Glintborg B, Filipescu I, Pérez-Pampin E, González-Utrilla A, Nevot MÁL, Conesa-Zamora P, Broeder AD, De Vita S, Jacobsen SEH, Collantes-Estevez E, Quartuccio L, Canzian F, Fonseca JE, Coenen MJH, Andersen V, Sainz J.

Pharmacogenomics J. 2019 Feb;19(1):83-96. doi: 10.1038/s41397-018-0057-x. Epub 2018 Oct 5. Erratum in: Pharmacogenomics J. 2019 Feb 14;:.

PMID:
30287909
36.

Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis.

Dekkers JS, Bergstra SA, Chopra A, Tikly M, Fonseca JE, Salomon-Escoto K, Huizinga TWJ, van der Woude D.

Rheumatology (Oxford). 2019 Jan 1;58(1):149-153. doi: 10.1093/rheumatology/key263.

PMID:
30204896
37.

The GO-DACT protocol: a multicentre, randomized, double-blind, parallel-group study to compare the efficacy of golimumab in combination with methotrexate (MTX) versus MTX monotherapy.

Vieira-Sousa E, Canhão H, Alves P, Rodrigues AM, Teixeira F, Tavares-Costa J, Bernardo A, Pimenta S, Pimentel-Santos F, Gomes JL, Aguiar R, Videira T, Pinto P, Catita C, Santos H, Borges J, Sequeira G, Ribeiro C, Teixeira L, Ávila-Ribeiro P, Martins FM, Ribeiro RM, Fonseca JE.

Acta Reumatol Port. 2018 Apr-Jun;43(2):80-92.

38.

Non-classical human leucocyte antigens in ankylosing spondylitis: possible association with HLA-E and HLA-F.

Santos MR, Couto AR, Foroni I, Bettencourt BF, Li Z, Meneses R, Wheeler L, Pereira J, Pimentel-Santos F, Fonseca JE, Alves H, Martinho A, Lima M, Brown MA, Bruges-Armas J.

RMD Open. 2018 Jun 28;4(1):e000677. doi: 10.1136/rmdopen-2018-000677. eCollection 2018.

39.

T Follicular Regulatory Cells Are Decreased in Patients With Established Treated Rheumatoid Arthritis With Active Disease: Comment on the Article by Liu et al.

Romão VC, Fonseca JE, Agua-Doce A, Graca L.

Arthritis Rheumatol. 2018 Nov;70(11):1893-1895. doi: 10.1002/art.40586. Epub 2018 Sep 3. No abstract available.

40.

Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations.

Canhão H, Rodrigues AM, Gregório MJ, Dias SS, Melo Gomes JA, Santos MJ, Faustino A, Costa JA, Allaart C, Gvozdenović E, van der Heijde D, Machado P, Branco JC, Fonseca JE, Silva JA.

Front Med (Lausanne). 2018 Mar 8;5:40. doi: 10.3389/fmed.2018.00040. eCollection 2018.

41.

Portuguese recommendations for the prevention, diagnosis and management of primary osteoporosis - 2018 update.

Rodrigues AM, Canhão H, Marques A, Ambrósio C, Borges J, Coelho P, Costa L, Fernandes S, Gonçalves I, Gonçalves M, Guerra M, Marques ML, Pimenta S, Pinto P, Sequeira G, Simões E, Teixeira L, Vaz C, Vieira-Sousa E, Vieira R, Alvarenga F, Araújo F, Barcelos A, Barcelos F, Barros R, Bernardes M, Canas da Silva J, Cordeiro A, Costa M, Cunha-Miranda L, Cruz M, Duarte AC, Duarte C, Faustino A, Figueiredo G, Fonseca JE, Furtado C, Gomes J, Lopes C, Mourão AF, Oliveira M, Pimentel-Santos FM, Ribeiro A, Sampaio da Nóvoa T, Santiago M, Silva C, Silva-Dinis A, Sousa S, Tavares-Costa J, Terroso G, Vilar A, Branco JC, Tavares V, Romeu JC, da Silva J.

Acta Reumatol Port. 2018 Jan-Mar;43(1):10-31.

42.

Efficacy and safety of intravitreal anti-tumour necrosis factor drugs in adults with non-infectious uveitis - a systematic review.

Leal I, Rodrigues FB, Sousa DC, Romão VC, Duarte GS, Carreño E, Dick AD, Marques-Neves C, Costa J, Fonseca JE.

Acta Ophthalmol. 2018 Sep;96(6):e665-e675. doi: 10.1111/aos.13699. Epub 2018 Mar 25. Review.

43.

Reply.

Fonseca VR, Romão VC, Fonseca JE, Agua-Doce A, Graca L.

Arthritis Rheumatol. 2018 Aug;70(8):1355-1356. doi: 10.1002/art.40487. Epub 2018 Jun 22. No abstract available.

44.

Effectiveness of a Referral Program for rheumatoid arthritis and axial spondyloarthritis Diagnosis at Primary Care Centers in Portugal - SIARA STUDY.

Fonseca JE, Pereira da Silva JA, Bernardes M, Cernadas R, Canas da Silva J, Costa L, Videira T, C Miranda L, Barcelos A, Laires PA, Dezerto R, D Pereira M, Vidal F, Cunha E, Morais A, Martins C, Mesquita R.

Acta Reumatol Port. 2018 Jan-Mar;43(1):40-51.

45.

The Ratio of Blood T Follicular Regulatory Cells to T Follicular Helper Cells Marks Ectopic Lymphoid Structure Formation While Activated Follicular Helper T Cells Indicate Disease Activity in Primary Sjögren's Syndrome.

Fonseca VR, Romão VC, Agua-Doce A, Santos M, López-Presa D, Ferreira AC, Fonseca JE, Graca L.

Arthritis Rheumatol. 2018 May;70(5):774-784. doi: 10.1002/art.40424. Epub 2018 Mar 25.

46.

Early arthritis induces disturbances at bone nanostructural level reflected in decreased tissue hardness in an animal model of arthritis.

Vidal B, Cascão R, Finnilä MAJ, Lopes IP, Saarakkala S, Zioupos P, Canhão H, Fonseca JE.

PLoS One. 2018 Jan 9;13(1):e0190920. doi: 10.1371/journal.pone.0190920. eCollection 2018.

47.

Corrigendum: Synovial tissue research: a state-of-the-art review.

Orr C, Vieira-Sousa E, Boyle DL, Buch MH, Buckley CD, Cañete JD, Catrina AI, Choy EHS, Emery P, Fearon U, Filer A, Gerlag D, Humby F, Isaacs JD, Just SA, Lauwerys BR, Goff BL, Manzo A, McGarry T, McInnes IB, Najm A, Pitzalis C, Pratt A, Smith M, Tak PP, Tas SW, Thurlings R, Fonseca JE, Veale DJ.

Nat Rev Rheumatol. 2017 Dec 19;14(1):60. doi: 10.1038/nrrheum.2017.206.

PMID:
29255214
48.

Treatment of Persistent Cutaneous Atrophy After Corticosteroid Injection With Fat Graft.

Martins N, Polido-Pereira J, Caneira M, Fonseca JE.

Reumatol Clin. 2019 Nov - Dec;15(6):e122-e124. doi: 10.1016/j.reuma.2017.09.002. Epub 2017 Dec 8. English, Spanish.

49.

Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?

Romão VC, Vital EM, Fonseca JE, Buch MH.

Arthritis Res Ther. 2017 Oct 24;19(1):239. doi: 10.1186/s13075-017-1445-3. Review.

50.

Effects of tofacitinib in early arthritis-induced bone loss in an adjuvant-induced arthritis rat model.

Vidal B, Cascão R, Finnilä MAJ, Lopes IP, da Glória VG, Saarakkala S, Zioupos P, Canhão H, Fonseca JE.

Rheumatology (Oxford). 2018 Aug 1;57(8):1461-1471. doi: 10.1093/rheumatology/kex258. Erratum in: Rheumatology (Oxford). 2019 Feb 1;58(2):371.

PMID:
28968875

Supplemental Content

Loading ...
Support Center